Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort-Reference-Cited by-同舟云学术

Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort

Published:2017-06-06 Issue:9 Volume:112 Page:1669-1679
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Knight Rod¹²,Roux Perrine³⁴,Vilotitch Antoine³⁴,Marcellin Fabienne³⁴,Rosenthal Eric⁵⁶,Esterle Laure⁷,Boué François⁸⁹,Rey David¹⁰,Piroth Lionel¹¹,Dominguez Stéphanie¹²,Sogni Philippe¹³¹⁴¹⁵,Salmon-Ceron Dominique¹⁵¹⁶,Spire Bruno³⁴,Carrieri Maria Patrizia³⁴,

Affiliation:

1. Faculty of Health Sciences; Simon Fraser University; Burnaby Canada

2. School of Population and Public Health; University of British Columbia; Vancouver Canada

3. Aix Marseille Université, INSERM, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale; Marseille France

4. ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur; Marseille France

5. Service de Médecine Interne et Cancérologie; Hôpital l'Archet, Centre Hospitalier Universitaire de Nice; France

6. Université de Nice-Sophia Antipolis; Nice France

7. INSERM, ISPED, Centre INSERM U1219-Bordeaux Population Health; Bordeaux France

8. Université Paris Sud; Paris France

9. Service Médecine interne et immunologie; AP-HP, Groupe Hospitalier Paris Sud, Hôpital Antoine-Béclère; Clamart France

10. Department of Infectious Diseases; Hôpitaux Universitaires; Strasbourg France

11. Centre Hospitalier Universitaire Dijon, and Unité Mixte de Recherche 1347; Université de Bourgogne; Dijon France

12. Service Immunologie clinique et maladies infectieuses, Immunologie clinique, AP-HP; Hôpital Henri Mondor; Créteil France

13. Service d'Hépatologie, Assistance Publique des Hôpitaux de Paris (AP-HP); Hôpital Cochin; Paris France

14. INSERM U-1223-Institut Pasteur; Paris France

15. Université Paris Descartes; Paris France

16. Service Maladies infectieuses et tropicales; AP-HP, Hôpital Cochin; Paris France

Funder

Michael Smith Foundation for Health Research

Agence Nationale de Recherches sur le Sida et les Hepatites Virales

Canadian Institutes of Health Research

French National Agency for Research on Aids and Viral Hepatitis (ANRS)

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/add.13851/fullpdf

Reference36 articles.

1. Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons;Petoumenos;Curr Opin HIV AIDS,2016

2. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study;Hassan;Int J Cancer,2008

3. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis;Brunet;Clin Infect Dis,2013

4. Cannabis use and reduced risk of insulin resistance in HIV-HCV infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH);Carrieri;Clin Infect Dis,2015

5. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C;Hezode;Gastroenterology,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection;Viruses;2024-09-05

2. Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH);JHEP Reports;2023-01

3. Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States;Drug and Alcohol Dependence;2022-12

4. HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data);AIDS Research and Therapy;2022-03-15

5. HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study);AIDS and Behavior;2021-04-27